No Detail Found!

Three years experience with glibenclamide in the maturity onset diabetes mellitus.

Author(s)
Zulfiqar Haider Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan
Surraiya Obaidullah Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan
Farhat Jabeen Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan
Fayyazuddin Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan
Abstract
Two hundred and eighty two patients with maturity onset diabetes mellitus were treated with Glibenclamide and followed up over a period ranging from three months up to 3 years. Excellent to good control was achieved in 179 out of 282 cases. A trial of Glibenclamide in 45 secondary failures on the sulphenylurea showed an improvement in status to satisfactory level in about 50% over the period of observation. Over three years period, the drug has been without any serious toxic effect in the dosage recommended.
Publication Details
Page(s) 15-20
DOI DOI not available
Published Journal: Pakistan Journal of Medical Research, Volume: 13, Issue: 1, Year: 1974

Request the full text from PASTIC

0

Citations

0

Downloads

35

Views